Study of the radiotherapy modality for patients with stage IIb-IIIb cervical stump cancer

To investigate the radiotherapy modality progress of stageIIb-IIIb cervical stump cancer. The clinical data of 13 patients with stageIIb-IIIb cervical stump cancer undergoing radiotherapy from January 2000 to April 2012 was reviewed. Before 2006, 8 patients received conventional external beam radiot...

Full description

Saved in:
Bibliographic Details
Published inChung-hua fu chʿan kʿo tsa chih Vol. 48; no. 9; p. 654
Main Authors An, Ju-Sheng, Huang, Man-Ni, Wu, Ling-Ying, Xu, Ying-Jie, Li, Xiao-Guang, Yu, Gao-Zhi, DU, Xiao-Meng, Dai, Jian-Rong
Format Journal Article
LanguageChinese
Published China 01.09.2013
Subjects
Brachytherapy
Disease-Free Survival
Humans
Neoplasm Recurrence, Local
Radiotherapy, Intensity-Modulated
Uterine Cervical Neoplasms
Online AccessGet more information

Cover

More Information
Summary:To investigate the radiotherapy modality progress of stageIIb-IIIb cervical stump cancer. The clinical data of 13 patients with stageIIb-IIIb cervical stump cancer undergoing radiotherapy from January 2000 to April 2012 was reviewed. Before 2006, 8 patients received conventional external beam radiotherapy and brachytherapy.Since 2006, 5 patients received intensity-modulated radiotherapy (IMRT) and brachytherapy. The median survival was 12-139 months. The median overall survivals and disease free survivals in the conventional radiotherapy (CRT) group were 57 months and 50 months, 3 cases of them recurred during 8-19 months and died of tumor progression.While, the median overall survivals and disease free survival in the IMRT group both were 21 months and nobody recurred. In the CRT group, 7 patients suffered toxicities, including 5 patients grade I-II acute rectum reaction, 2 patients grade I bladder reaction; and 3 had grade I-III, late rectum reaction, 2 patients for grade II bladder late reaction.In the IMR
ISSN:0529-567X